12 completed. 12 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 12 | Completed 12 |
| Phase 2 | 3 | Completed 3 |
Follow Angina Pectoris: new trials by email Literature Review of Angina Pectoris trials Research Report on Angina Pectoris
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial) AdVEGFXC1 - Coronary Artery Disease, Ischemia | Phase 1 / Phase 2 | Completed | XyloCor Therapeutics, Inc. | 41 | 2020-01-24 | 2024-01-30 |
| Cardioprotective Effects of GLP-1 and Their Mechanisms GLP-1 (7-36) amide, Glibenclamide - Angina Pectoris | Phase 1 | Completed | Papworth Hospital NHS Foundation Trust | 32 | 2014-07-01 | 2016-04-11 |
| A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers Dilatrend 64mg capsule - Chronic Stable Angina | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 24 | 2011-07-01 | 2011-12-22 |
| Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule Dilatrend SR capsule - Chronic Stable Angina | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 30 | 2011-06-01 | 2012-02-15 |
| A Study To Evaluate The Effect of T89(Dantonic®)On P450 Enzymes T89(Dantonic) - Stable Angina | Phase 1 | Completed | Tasly Pharmaceuticals, Inc. | 24 | 2011-01-01 | 2012-11-08 |
| Adenosine Cardioplegia; Improved Cardioprotection? Adenosine - Angina Pectoris | Phase 1 / Phase 2 | Completed | University Hospital of North Norway | 60 | 2010-04-01 | 2011-09-30 |
| EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease VEGF-D gene transfer - Angina Pectoris, Myocardial Infarction | Phase 1 | Completed | Kuopio University Hospital | 30 | 2010-01-10 | 2018-03-08 |
| Extracorporeal Shockwave Therapy for the Treatment of Advanced Angina Pectoris Cardiac Extracorporeal Shockwave Therapy generator (Cardiospec) - Refractory Angina Pectoris | Phase 1 | Completed | Medispec | 33 | 2009-01-01 | 2013-02-20 |
| Safety and Efficacy of Autologous Endothelial Progenitor Cell CD 133 for Therapeutic Angiogenesis Selected CD 133+ cells - Coronary Artery Disease, Refractory Angina | Phase 1 / Phase 2 | Completed | Pilar Jimenez Quevedo | 28 | 2008-05-01 | 2013-08-06 |
| A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014) telcagepant, Placebo to telcagepant - Angina Pectoris, Coronary Heart Disease | Phase 1 | Completed | Merck Sharp & Dohme LLC | 64 | 2008-02-12 | 2018-10-18 |
| Stem Cell Study for Patients With Heart Disease Cell Therapy - Autologous CD34 Positive Cells - Chest Pain, Myocardial Ischemia | Phase 1 | Completed | Losordo, Douglas, M.D. | 24 | 2004-01-01 | 2008-01-29 |
| To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg Atenolol (Tenormin) 100 mg Tablets Zeneca (Astra Zeneca Pharmaceutical), Atenolol 100 mg Tablets (Geneva Pharmaceutical, Inc.) - Angina, Hypertension | Phase 1 | Completed | Sandoz | 28 | 2000-11-01 | 2017-03-28 |
Angina, Stable (3) · Coronary Artery Disease (3) · Myocardial Ischemia (3) · Chest Pain (2) · Heart Diseases (2) · Cardiovascular Diseases (1) · Coronary Disease (1) · Hypertension (1) · Ischemia (1) · Myocardial Infarction (1) · Myocardial Reperfusion Injury (1)
Neurologic Manifestations (12) · Pain (12) · Pathological Conditions, Signs and Symptoms (12) · Signs and Symptoms (12) · Vascular Diseases (12) · Cardiovascular Diseases (11) · Chest Pain (10) · Heart Diseases (10) · Myocardial Ischemia (9) · Arterial Occlusive Diseases (3) · Arteriosclerosis (3) · Pathologic Processes (3) · Coronary Disease (2) · Cardiomyopathies (1)
Adenosine (1) · Atenolol (1) · Carvedilol (1) · Glyburide (1) · T89 herbal drug (1) · glucagon-like peptide 1 (7-36)amide (1) · telcagepant (1)
Chong Kun Dang Pharmaceutical (2) · Kuopio University Hospital (1) · Losordo, Douglas, M.D. (1) · Medispec (1) · Merck Sharp & Dohme LLC (1) · Papworth Hospital NHS Foundation Trust (1) · Pilar Jimenez Quevedo (1) · Sandoz (1) · Tasly Pharmaceuticals, Inc. (1) · University Hospital of North Norway (1) · XyloCor Therapeutics, Inc. (1)
United States (3) · South Korea (2) · Finland (1) · Netherlands (1) · Norway (1) · Spain (1) · United Kingdom (1)
Juha Hartikainen (1) · KS Bae, Ph.D (1) · Pilar Jimenez-Quevedo, MD,PhD (1) · Prof. Johannes Waltenberger, MD, PhD (1) · Ronald Goldwater, M.D. (1) · Stephen P Hoole, MD (1)
PMID 17562958, PMID 22278333, PMID 22964356, PMID 27431258, PMID 34224684, PMID 35750637, PMID 37503661, PMID 38696284
2008 (1)